“동래오피🌶 ┽OPdal010.COM┍오피달리기 🎏동래대딸방🈚️동래풀싸롱🍪동래립카페🏂동래대딸방💼동래스웨디시🔑동래건마🎫”的搜索结果，显示 291-300 项，共有 17275 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with ...

3. 乳腺癌- 医生与科室- 妙佑医疗国际

   这部分内容没有英语版本。 这部分内容没有阿拉伯语版本。

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Effects of Cognitive Function, Post-op Fatigue and Quality of Life Comparing General vs Regional Anesthesia for Non-eloquent Brain Tumors Resection.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate how well bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...